Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply
Lancet
.
2015 Nov 28;386(10009):2143.
doi: 10.1016/S0140-6736(15)01052-1.
Authors
Sean Kehoe
1
,
Matthew Nankivell
2
Affiliations
1
School of Cancer Sciences, University of Birmingham, Birmingham, UK.
2
Medical Research Council Clinical Trials Unit, University College London, London WC2B 6NH, UK. Electronic address: m.nankivell@ucl.ac.uk.
PMID:
26638963
DOI:
10.1016/S0140-6736(15)01052-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / surgery*
Grants and funding
MC_U122861379/MRC_/Medical Research Council/United Kingdom
MC_UU_12023/28/MRC_/Medical Research Council/United Kingdom